KLHL23 and cancer: GO enrichment pathways in the KLHL23 high expression group across cancers were similar and could be classified into three categories: immune response and T cell activation pathways, extracellular matrix adhesion pathways, and RNA splicing and ion transport pathways (Supplementary Figure 3).